Impact of cause of death adjudication on the results of the European prostate cancer screening trial

BACKGROUND: The European Randomised Study of Prostate Cancer Screening has shown a 21% relative reduction in prostate cancer mortality at 13 years. The causes of death can be misattributed, particularly in elderly men with multiple comorbidities, and therefore accurate assessment of the underlying c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Walter, Stephen D, de Koning, Harry J, Hugosson, Jonas, Talala, Kirsi, Roobol, Monique J, Carlsson, Sigrid, Zappa, Marco, Nelen, Vera, Kwiatkowski, Maciej, Páez, Álvaro, Moss, Sue, Auvinen, Anssi
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2017
Assuntos:
Epidemiology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5220145/
https://ncbi.nlm.nih.gov/pubmed/27855442
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2016.378
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados